医学
肝硬化
医疗补助
肝性脑病
重症监护医学
糖尿病
人口
肝病
非酒精性脂肪肝
疾病
医疗保健
失代偿
内科学
急诊医学
脂肪肝
环境卫生
经济
经济增长
内分泌学
作者
Archita P. Desai,Nancy Reau
标识
DOI:10.1080/21548331.2016.1142828
摘要
Advanced liver disease is becoming more prevalent in the United States. This increase has been attributed largely to the growing epidemic of nonalcoholic fatty liver disease and an aging population infected with hepatitis C. Complications of cirrhosis are a major cause of hospital admissions and readmissions. It is important to target efforts for preventing rehospitalization toward patients with cirrhosis who are at the highest risk for readmission, such as those who have high Model for End-Stage Liver Disease scores, are at risk for fluid/electrolyte abnormalities or overt hepatic encephalopathy recurrence, and those who have comorbid conditions (e.g. diabetes). The heart failure management paradigm may provide valuable insights for managing patients with cirrhosis, given the extensive research on preventing hospital readmission and improving health care utilization in this subpopulation. As quality measures related to hospital readmissions for cirrhosis and its complications are adopted by the Centers for Medicare & Medicaid Services and private payers in the future, understanding drivers of hospital readmissions and health care utilization in this vulnerable population are key to improving quality measure performance.
科研通智能强力驱动
Strongly Powered by AbleSci AI